MAREL Marel hf.

Marel - Date of transaction 1.11.2018

Marel - Date of transaction 1.11.2018

Auðkenni útgefanda/Trade ticker:  

MARL

Nafn útgefanda/Issuer:

Marel hf.

Dagsetning tilkynningar/Date of announcement

01.11.2018

Nafn fjárhagslega tengds aðila sem á viðskipti/Name of related party trading the shares:

Hofgarðar ehf.

Nafn fruminnherja/Name primary insider:

Helgi Magnússon

Tengsl fruminnherja við útgefanda/Insider's relation with the issuer:

Stjórnarmaður í Marel hf./Member of Board of Directors of Marel hf.

Dagsetning viðskipta/Date of transaction:

01.11.2018

Tímasetning viðskipta/Time of transaction:

Tegund fjármálagernings/Type of financial instrument:

Hlutabréf/Equities

Kaup eða sala/Buy or Sell:

Kaup/Buy

Fjöldi hluta/Number of shares:

260.000

Verð pr. Hlut/Price per share:

386

Fjöldi hluta í eigu fruminnherja eftir viðskipti/Primary insider's holdings after the transaction:

0

Fjöldi hluta sem fruminnherji á kauprétt að/Primary insider's option holdings after the transaction:

Fjöldi hluta fjárhagslega tengdra aðila eftir viðskipti/Related parties' holdings after the transaction:

3.039.044

Dagsetning lokauppgjörs*/Date of settlement*:

Athugasemdir*/Comments*:                                                                                                                               

                                                                                                                                                                                 



EN
01/11/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Marel hf.

Martijn Den Drijver
  • Martijn Den Drijver

MAREL HF : A solid quarter, 2024 guidance to be met, slight delay in J...

>Beats on order intake and EBIT (margin), sales a miss, ND/EBITDA down - MAREL beat css on order intake which is encouraging, also because order intake is up both QoQ and YoY (+3%). Sales of €387m missed css by 4%, primarily because of 1/ weak ad-hoc orders as order intake has been weak for a few quarters now and 2/weak sales in Poultry and Fish. Adjusted EBIT came in at €36.2m or a margin of 9.4% versus css of €33.4m or a margin of 8.3%. That is a beat of 8% on adj....

ResearchPool Subscriptions

Get the most out of your insights

Get in touch